MedPath

Treatment of Adolescent Suicide Attempters (TASA)

Phase 2
Completed
Conditions
Suicide, Attempted
Depression
Registration Number
NCT00080158
Lead Sponsor
New York State Psychiatric Institute
Brief Summary

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Detailed Description

Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies.

Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • At least one suicide attempt or interrupted attempt within the past 45 days
  • Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

Columbia University at the New York State Psychiatric Institute

🇺🇸

New York, New York, United States

New York University Child Study Center

🇺🇸

New York, New York, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

University of Pittsburgh - Western Psychiatric Institute and Clinic

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Texas, Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath